BioMedWire
Media & Internet · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1728 Ocean Ave Pmb Bmw276, San Francisco...Phone Number
(415) 949-5050Website
www.biomedwire.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About BioMedWire
BioMedWire (BMW) is a diversified financial news and publishing company that specializes in the medical and biotechnology sectors. The company offers a range of services including brand awareness, corporate communications, press release enhancement, and social media solutions, aimed at helping public companies, start-ups, and private firms enhance their market visibility. With an extensive network of over 5,000 distribution outlets, BioMedWire maximizes exposure for its clients to a diverse audience of journalists, investors, and market participants. As a technology-driven communications platform, BMW aggregates and distributes news on emerging market opportunities in life sciences, pharmaceuticals, and related fields.Explore more
BioMedWire Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioMedWire your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once BioMedWire has new funding data
Product Launch: Get notified when BioMedWire launches new products
Check if BioMedWire has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at BioMedWire
Check out if BioMedWire is spiking on competitors!
Earning: See what the market has to say on BioMedWire recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if BioMedWire had a recent Job posting/layoffs
BioMedWire, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to BioMedWire
Compare insights from companies similar to BioMedWire, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BioMedWire is experiencing very low activity levels compared to other companies in the Media & Internet sector.
What does this means?
BioMedWire is drawing exceptional interest within the Media & Internet industry, suggesting notable developments or strong market momentum, learn more about BioMedWire.
BioMedWire Tech Stack
A closer look at the technologies used by BioMedWire
BioMedWire News & Media
Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion
AUSTIN, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: With oncology drug-development expenses continuing to rise and regulatory approvals becoming harder to secure, biotechnology companies are placing greater emphasis on extracting more value from existing therapies through cutting-edge delivery technologies rather than betting solely on the discovery of wholly new compounds. Across the life sciences industry, mounting interest is being directed toward nanoparticle-baseOncotelic Therapeutics Inc. (OTCQB: OTLC) Advancing Proprietary Solutions Focused on Nanotechnology-Enabled Drug Delivery, AI-Enhanced Biomedical Infrastructure
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.IBN Announces Latest Episode of The BioMedWire Podcast Featuring Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd.
Disseminated on behalf of Quantum BioPharma, may include paid advertisements.How Advanced Drug Delivery Could Improve Existing Cancer Treatments
AUSTIN, Texas, June 01, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: As oncology drug-development costs continue climbing and regulatory pathways become increasingly complex, biotechnology companies are placing renewed emphasis on improving existing therapeutics through advanced delivery technologies rather than relying exclusively on discovering entirely new drugs. Across the healthcare sector, growing attention is being directed toward nanoparticle delivery systems, intravenous refo
Read more news
Top Media & Internet Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioMedWire
Sign Up For FreeTo access detailed company insights
BioMedWire (BMW) is a diversified financial news and publishing company that specializes in the medical and biotechnology sectors. The company offers a range of services including brand awareness, corporate communications, press release enhancement, and social media solutions, aimed at helping public companies, start-ups, and private firms enhance... Read More
